News & Events

The Astrogentix News and Events Center provides members of the media and the public timely and relevant information about our company. In this section you will find information and resources including current and archived Astrogenetix press releases, details on upcoming company events, and exciting business opportunities.

Syndicate content Subscribe to our news feed

06.01.2011 ASTROGENETIX’S VACCINE RESEARCH CONTINUES ON ENDEAVOUR’S FINAL FLIGHT

NASA astronauts onboard Space Shuttle Endeavour’s final mission to the International Space Station (ISS), completed a research payload for Astrogenetix, a commercial biotech company based out of Austin, Texas. The research that returned upon the successful landing of STS-134 this morning is the latest in a series focused on changes that occur to methicillin-resistant Staphylococcus aureus (MRSA) and Salmonella in microgravity....
> Read More

02.24.2011 ASTROGENETIX’S MRSA RESEARCH CONTINUES ON DISCOVERY’S LAST MISSION

NASA astronauts onboard Space Shuttle Discovery’s final mission to the International Space Station (ISS) will carry out the eleventh scientific payload for Astrogenetix, a commercial biotech company based out of Austin, Texas. The research on STS-133 will focus on changes that occur to methicillin-resistant Staphylococcus aureus (MRSA) in microgravity, which can be targeted to create new vaccines and therapeutics....
> Read More

05.26.2010 ASTROGENETIX PERFORMS DRUG DEVELOPMENT IN MICROGRAVITY

Space Shuttle Atlantis returned from the International Space Station (ISS) landing at the Kennedy Space Center this morning with the tenth scientific payload for Astrogenetix, a commercial biotech company based out of Austin, Texas. Astrogenetix is conducting research on methicillin-resistant Staphylococcus aureus (MRSA) as part of the ISS National Laboratory Pathfinder Vaccine (NLP-V) missions....
> Read More

04.06.2010 ASTROGENETIX NARROWS IN ON MRSA VIRULENCE ONBOARD DISCOVERY

Astronauts on board Space Shuttle Discovery (STS-131) activated an experiment this morning as part of the ninth scientific payload for Astrogenetix, an Austin, Texas-based commercial biotech company. Astrogenetix is conducting the International Space Station National Laboratory Pathfinder Vaccine (NLP-V) missions to take advantage of the unique conditions of microgravity to uncover changes in bacteria that can be targeted to create new vaccines and therapeutics....
> Read More

02.08.2010 ASTROGENETIX CONTINUES MRSA VACCINE DEVELOPMENT ONBOARD ENDEAVOR

Space Shuttle Endeavor lifted off from NASA’s Kennedy Space Center this morning, carrying on board the eighth scientific payload for Astrogenetix, a commercial biotech company created to use microgravity to develop the foundation of new medicines....
> Read More